Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391521 · ClinicalTrials.gov registry record · Phase 1
AS703569 Phase I in Patients With Solid Tumours
A Phase 1 study, sponsored by EMD Serono.
- Completed
- Registry status
- Phase 1
- Development phase
- 104
- Enrollment target
NCT00391521 is a Phase 1 study that has completed, run by EMD Serono. The registered enrollment target is 104 participants.
The verdict
NCT00391521, a Phase 1 study, has completed, sponsored by EMD Serono.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 104 participants
- Enrollment target
Study Summary
This is a Phase I trial. Some specific protocol information is proprietary and is not publicly available at this time. Full information will be provided to trial participants.
Interventions
- DRUG AS703569
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2006-08 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00391521
The ClinicalTrials.gov registry entry for NCT00391521 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AS703569 is the first listed.
NCT00391521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00391521 about?
NCT00391521 is a clinical study titled "AS703569 Phase I in Patients With Solid Tumours". This is a Phase I trial. Some specific protocol information is proprietary and is not publicly available at this time. Full information will be provided to trial participants.
What is the current status of trial NCT00391521?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 104 participants. The study started on 2006-08. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00391521?
The interventions under investigation include: AS703569 (DRUG).
Who is sponsoring clinical trial NCT00391521?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.